Lyell Immunopharma, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 CCCC
|
C4 Therapeutics, Inc. | $6.10 | $320.64 M | -1.97 | 145 | $20.76 M |
 CGEM
|
Cullinan Oncology, Inc. | $15.98 | $1.29 B | -7.16 | 85 | $0 |
 CRNX
|
Crinetics Pharmaceuticals, Inc. | $57.88 | $3.53 B | -11.86 | 290 | $4.01 M |
 EWTX
|
Edgewise Therapeutics, Inc. | $35.91 | $1.65 B | -11.47 | 97 | $0 |
 GBIO
|
Generation Bio Co. | $2.18 | $216.88 M | -1.28 | 174 | $5.90 M |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $9.36 | $243.38 M | -1.59 | 129 | $0 |
|
INBX
|
Inhibrx Biosciences, Inc. | $15.70 | $241.02 M | -1.44 | 166 | $1.80 M |
|
IPSC
|
Century Therapeutics, Inc. | $1.33 | $244.54 M | -1.32 | 152 | $2.24 M |
 KRON
|
Kronos Bio, Inc. | $0.95 | $44.62 M | -0.37 | 58 | $6.29 M |
|
MLYS
|
Mineralys Therapeutics, Inc. | $13.49 | $652.38 M | -6.03 | 28 | $0 |
|
MRUS
|
Merus N.V. | $51.75 | $3.50 B | -19.38 | 172 | $43.95 M |
 NKTX
|
Nkarta, Inc. | $3.25 | $465.09 M | -2.81 | 150 | $0 |
 NUVB
|
Nuvation Bio Inc. | $2.32 | $684.66 M | -8.66 | 167 | $0 |
 RVMD
|
Revolution Medicines, Inc. | $56.75 | $6.66 B | -10.51 | 443 | $11.58 M |
 SANA
|
Sana Biotechnology, Inc. | $3.39 | $1.55 B | -4.59 | 328 | $0 |
|
STTK
|
Shattuck Labs, Inc. | $1.20 | $333.81 M | -3.64 | 75 | $1.66 M |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |